M. Bemer

发表

A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients

M. Sorror, B. Sandmaier, J. McCune, 2013, Cancer Chemotherapy and Pharmacology.

Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization

J. Barrett, N. Holford, J. McCune, 2013, Clinical Cancer Research.

Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II

J. McCune, J. Long-Boyle, M. Bemer, 2016, Clinical Pharmacokinetics.

Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study

J. F. Morton, G. Gottlieb, P. Drain, 2022, Journal of Clinical Virology.

Pharmacokinetic and pharmacodynamic analysis of inosine monophosphate dehydrogenase activity in hematopoietic cell transplantation recipients treated with mycophenolate mofetil.

Brian R. Phillips, B. Sandmaier, B. Storer, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients

S. Heimfeld, B. Sandmaier, B. Storer, 2015, Cancer Chemotherapy and Pharmacology.

Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation.

Brian R. Phillips, B. Sandmaier, B. Storer, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation.

B. Sandmaier, B. Storer, M. Boeckh, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

RECIPIENT PRETRANSPLANT INOSINE MONOPHOSPHATE DEHYDROGENASE ACTIVITY IN NONMYELOABLATIVE HCT

Brian R. Phillips, B. Sandmaier, B. Storer, 2014 .

Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I

J. McCune, M. Bemer, Meagan J. Bemer, 2015, Clinical Pharmacokinetics.

High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients

M. Sorror, B. Sandmaier, A. Mrhar, 2013, International journal of clinical pharmacology and therapeutics.

Variation in Prescribing Patterns and Therapeutic Drug Monitoring of Intravenous Busulfan in Pediatric Hematopoietic Cell Transplant Recipients

J. Barrett, D. Blough, J. McCune, 2013, Journal of clinical pharmacology.

Accuracy of 2 Rapid Antigen Tests During 3 Phases of SARS-CoV-2 Variants

P. Drain, M. Gates-Hollingsworth, D. Aucoin, 2022, JAMA network open.

Population Pharmacokinetics and Dose Optimization of Mycophenolic Acid in HCT Recipients Receiving Oral Mycophenolate Mofetil

B. Sandmaier, D. Maloney, D. Mager, 2013, Journal of clinical pharmacology.

A Limited Sampling Schedule to Estimate Mycophenolic Acid Area Under the Concentration‐Time Curve in Hematopoietic Cell Transplantation Recipients

B. Sandmaier, D. Salinger, P. Vicini, 2012, Journal of clinical pharmacology.

Performance of anterior nares and tongue swabs for nucleic acid, Nucleocapsid, and Spike antigen testing for detecting SARS-CoV-2 against nasopharyngeal PCR and viral culture

P. Drain, Linhui Hao, D. Boyle, 2022, International Journal of Infectious Diseases.